Top news of the week: 14.04.2020.
#CoronaVirus #COVID19 #pharmaceuticals #biotechnology #CoronaOutbreak #CoronaPandemic #biospace #lifesciences #Biopharma #digitization
Companies And Industries
#Biopharma Update on the Novel #Coronavirus #COVID19 https://t.co/pSgEym0n3y https://t.co/0FE4XDKH39
OpenBiopharma Update on the Novel Coronavirus: April 10
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 10, 2020.
Biopharma deals and M&As down slightly, but respectable showing despite pandemic https://t.co/JpPsXHqzW0
OpenBiopharma deals and M&As down slightly, but respectable showing despite pandemic
With nearly a quarter of the activity announced in March focused on COVID-19, the first quarter of 2020 appears to be on target to beat the deal and M&A values of two of the last three ...
The Dish’s Weekly Biotechnology News Wrap Up – April 10, 2020
*|RSSFEED:DATE|* Incase you missed it. We summarize the week's top biotechnology stories.
Investors must be ready for the #digitization of #biotech. What do you think? 🧐Read the full article by subscribing to Labiotech Insider 30 days for free: 👉🏻 https://t.co/FcJ0AM3Iwx 👈🏻#venturecapital #investment #startup #interview #LBRefresh #membership https://t.co/Uou1rT9Azk
OpenInvestors Must Be Ready for the Digitization of Biotech
For a few decades, the worlds of biotech and digital technology have been on separate paths. Franck Lescure, Partner at the French VC firm Elaia Partners, explains how the two fields are ...
Biotech Beach Emergent BioSolutions Aims to Fight COVID-19 https://t.co/245iy7awij https://t.co/CnFsbM42M5
OpenBiotech Beach Emergent BioSolutions Aims to Fight COVID-19
Biopharma companies are attacking the COVID-19 pandemic from many fronts. Emergent BioSolutions is among those leading the fight.
RT @DanBudwick: .@ThirdRockV partner Abbie Celniker & @EQRxINC founder Alexis Borisy catch up w/ @statnews on life in biotech amidst the COVID-19 pandemic https://t.co/IGH1WU5o0c
OpenBiotech in the time of coronavirus: Pondering the future of ‘JPM Week’
In this edition: Will #JPM21 be a thing? Also, some straight talk from Alexis Borisy, Daphne Zohar and Abbie Celniker, and another biotech investor survey.
Martin Shkreli Pleads for 3-Month Prison Furlough to Help COVID-19 R&D Efforts https://t.co/pJxKNUTMtU https://t.co/oFFbVE2OTi
OpenMartin Shkreli Pleads for 3-Month Prison Furlough to Help COVID-19 R&D Efforts
Disgraced pharma executive Martin Shkreli is pleading to be temporarily let out of prison in order to join in the fight against COVID-19, the disease that has swept across the globe ...
RT @adamfeuerstein: Biotech in the time of coronavirus: The return of mergers, acquisitions, and deals https://t.co/IMQ6jAdYTo Also, did $SAGE 's CEO take a paycut? American First and $GILD, plus more...
OpenBiotech in the time of coronavirus: The return of mergers, acquisitions, and deals
In this week's column: When will biotech M&A return? Did Sage Therapeutics CEO take a pay cut? And biotech in an America First world.